Cyclic trans-phosphorylation in a homodimer as the predominant mechanism of EGFRvIII action and regulation
Sign Up to like & getrecommendations! Published in 2018 at "Oncotarget"
DOI: 10.18632/oncotarget.24058
Abstract: Despite intensive research no therapies targeted against the oncogenic EGFRvIII are present in the clinic. One of the reasons is the elusive nature of the molecular structure and activity of the truncated receptor. The recent… read more here.
Keywords: trans phosphorylation; type egfr; mutant receptor; receptor ... See more keywords